Natera, Inc. (NASDAQ:NTRA), standing third among the best biotech stocks to buy according to billionaires, is a clinical genetic testing company specializing in non-invasive cell-free DNA (cfDNA ...

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

The New York StateWide Senior Action Council (StateWide), an organization dedicated to advocacy for the rights of seniors in New York State, today announced its Medicare Fraud of the Month for March: ...

Patients can now easily buy these tests, but cardiologists must consider their quality when using the information to guide ...

Research on behalf of the U.S. shrimp industry found as much as 70% of shrimp sold in restaurants as domestic is anything but ...

Genotyping: Essential for understanding genetic predispositions, this technology is becoming an integral part of consumer genomics. US, NY, UNITED STATES, March 20, 2025 /EINPresswire / -- Consumer ...

The Shasta County Coroner's Office has teamed with a Texas firm to help identify a man who was killed more than 20 years ago ...

Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular ...

Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...

Sponsored genetic testing programs can run afoul of federal laws, including the FCA and AKS, if not designed correctly. Experts at Morrison Foerster share best practices for compliance.